Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/05/2014US20140155396 C-Met Modulators and Method of Use
06/05/2014US20140155393 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
06/05/2014US20140155388 Methods and compositions for self-regulated release of active pharmaceutical ingredient
06/05/2014US20140155385 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk inhibitors
06/05/2014US20140155384 Compounds and methods of treating diabetes
06/05/2014US20140155383 Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155378 c-Met Modulators and Method of Use
06/05/2014US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
06/05/2014US20140155373 Novel compounds
06/05/2014US20140155372 Combinations of akt and mek inhibitor compounds, and methods of use
06/05/2014US20140155369 Preventives/remedies for stress urinary incontinence and method of screening the same
06/05/2014US20140155368 Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditions
06/05/2014US20140155367 Compounds and compositions for the treatment of parasitic diseases
06/05/2014US20140155364 Formulations of deoxycholic acid and salts thereof
06/05/2014US20140155362 Bhq-conjugates, and related compounds, methods of making the same, and methods of use thereof
06/05/2014US20140155361 Method for treating lung disease
06/05/2014US20140155360 Calcium Formate for Use as a Dietary Supplement
06/05/2014US20140155358 Therapeutic Compounds
06/05/2014US20140155349 Health Care
06/05/2014US20140155348 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
06/05/2014US20140155347 Spray Drying of High Molecular Weight Hyaluronic Acid
06/05/2014US20140155344 Combination therapy methods for treating proliferative diseases
06/05/2014US20140155343 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
06/05/2014US20140155342 Patch containing diclofenac and thiocolchicoside
06/05/2014US20140155341 Use of ss'-dimethyl-gliotoxin as diagnostic marker of pathologies caused by gliotoxin-producing fungi or their derivatives
06/05/2014US20140155339 Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
06/05/2014US20140155338 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
06/05/2014US20140155335 Elastin protective polyphenolics and methods of using the same
06/05/2014US20140155334 Polyphosphate and pyrophosphate derivative of saccharides
06/05/2014US20140155332 Selective inhibitors of tumor-initiating cells
06/05/2014US20140155320 Use of storage stable viscous phospholipid depot to treat wounds
06/05/2014US20140154797 Lysis/Resealing Process and Device for Incorporating an Active Ingredient, in Particular Asparaginase or Inositol Hexaphosphate, in Erythrocytes
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/05/2014US20140154344 Autism improving agent and autism improving tea
06/05/2014US20140154338 Skin cream
06/05/2014US20140154337 Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms
06/05/2014US20140154332 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
06/05/2014US20140154330 Spherical particles of clopidogrel bisulfate, pharmaceutical composition comprising the same, and preparation method thereof
06/05/2014US20140154323 Method for treating bronchial diseases
06/05/2014US20140154322 For injectable formulations containing asenapine and method of treatment using same
06/05/2014US20140154321 Sustained release delivery devices
06/05/2014US20140154320 Extended-release formulation for reducing the frequency of urination and method of use thereof
06/05/2014US20140154317 Pharmaceutical Composition for Treatment of Helicobacter Pylori Associated Diseases
06/05/2014US20140154316 Novel pharmaceutical composition
06/05/2014US20140154314 Delayed-release formulation for reducing the frequency of urination and method of use thereof
06/05/2014US20140154312 Oral targetted drug delivery system
06/05/2014US20140154310 Pharmaceutical compositions comprising fatty acids
06/05/2014US20140154309 Solid ganaxolone compositions and methods for the making and use thereof
06/05/2014US20140154306 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
06/05/2014US20140154305 Use of umirolimus and its derivatives for treating cancer
06/05/2014US20140154304 Combination therapy with volasertib
06/05/2014US20140154303 Treating cancer by inhibiting expression of olfm4, sp5, tob1, arid1a, fbn1 or hat1
06/05/2014US20140154302 Antimicrobial compositions for treating microbial infections
06/05/2014US20140154301 Medicinal delivery system and related methods
06/05/2014US20140154300 Methods and compositions for treatment of lesioned sites of body vessels
06/05/2014US20140154293 Intravaginal delivery system
06/05/2014US20140154290 Composition for prevention and treatment of allergic and/or inflammatory diseases
06/05/2014US20140154266 Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
06/05/2014US20140154264 Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition
06/05/2014US20140154262 Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
06/05/2014US20140154246 Cai-based systems and methods for the localized treatment of ocular and other diseases
06/05/2014US20140154244 Methods of Treating Primary Brain Tumors by Administering Letrozole
06/05/2014US20140154240 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
06/05/2014US20140154232 Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing
06/05/2014US20140154220 Methods and Compositions for Improved Tissue Regeneration by Suppression of Interferon-Gamma and Tumor Necrosis Factor-Alpha
06/05/2014US20140154218 Anti-allergic agent
06/05/2014US20140154216 Virus strains
06/05/2014US20140154215 Herpes virus strains
06/05/2014US20140154211 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
06/05/2014US20140154210 Solid Forms of a Thiophosphoramidate Nucleotide Prodrug
06/05/2014US20140154208 Novel [N-Me-4-hydroxyleucine]-9-Cyclosporin Analogues for Treatment and Prevention of Hepatitis C Infection
06/05/2014US20140154205 Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
06/05/2014US20140154204 Silane-containing moisture-curable tissue sealant
06/05/2014US20140154203 Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using The Same
06/05/2014US20140154180 Pharmacophores for Amyloid Fibers Involved in Alzheimer's Disease
06/05/2014US20140150788 Dry Powder For Inhalation
06/05/2014DE112012002813T5 Kombinationsbehandlung (zB mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) Combination treatment (eg with ABT-072 or ABT-333 of DAAs for use in the treatment of HCV)
06/05/2014DE102012222365A1 Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen Composition for use in the prophylaxis of post-surgical adhesions
06/05/2014DE102012111674A1 New nucleoside derivatives useful for treating diabetes mellitus, which is used with further active substances
06/05/2014DE102012022778A1 Medicine useful for treating cancer, heart attack and tuberculosis, comprises active ingredient e.g. theobromine which is alkaloid obtained from cocoa, lichenin which is antibiotic derived from oats and caffeine obtained from coffee
06/05/2014CA2863243A1 Rafamycin analogs and methods for making same
06/04/2014EP2738176A1 Water soluble camptothecin derivative, pharmaceutical composition and use thereof
06/04/2014EP2738174A2 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient
06/04/2014EP2738173A1 Heterocyclic compounds as inhibitors of the sodium iodide symporter
06/04/2014EP2738172A1 New bicyclic compounds as crac channel modulators
06/04/2014EP2738170A1 Heterocyclic compound
06/04/2014EP2738169A1 Oxazolidinone compounds and their uses in preparation of antibiotics
06/04/2014EP2738168A1 N-hetero-ring-substituted amide derivative
06/04/2014EP2738167A2 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants)
06/04/2014EP2738163A1 Amidine compound or salt thereof
06/04/2014EP2738156A1 9-aminomethyl substituted tetracycline compound
06/04/2014EP2737927A1 Imidazo[1,2a]pyrazines and compositions comprising them for the treatment of parasitic diseases
06/04/2014EP2737908A1 Viscoelastic gels in ophthalmic surgery
06/04/2014EP2737904A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
06/04/2014EP2737902A1 Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field
06/04/2014EP2737901A1 Therapeutic Use of Compounds
06/04/2014EP2737900A1 Ndm inhibitor
06/04/2014EP2737898A1 Compositions comprising Tramadol and Celecoxib in the treatment of pain
06/04/2014EP2737897A2 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 7860